- Home
- USCB vs ENGN Comparison
USCB vs ENGN Comparison
Compare USCB & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- ENGN
- Stock Information
- Founded
- USCB 2002
- ENGN 1999
- Country
- USCB United States
- ENGN Canada
- Employees
- USCB N/A
- ENGN N/A
- Industry
- USCB Major Banks
- ENGN
- Sector
- USCB Finance
- ENGN
- Exchange
- USCB Nasdaq
- ENGN Nasdaq
- Market Cap
- USCB 316.4M
- ENGN 321.5M
- IPO Year
- USCB 2021
- ENGN N/A
- Fundamental
- Price
- USCB $17.40
- ENGN $6.96
- Analyst Decision
- USCB Strong Buy
- ENGN Buy
- Analyst Count
- USCB 3
- ENGN 8
- Target Price
- USCB $22.00
- ENGN $21.50
- AVG Volume (30 Days)
- USCB 20.4K
- ENGN 302.0K
- Earning Date
- USCB 10-30-2025
- ENGN 09-11-2025
- Dividend Yield
- USCB 2.32%
- ENGN N/A
- EPS Growth
- USCB 67.08
- ENGN N/A
- EPS
- USCB 1.47
- ENGN N/A
- Revenue
- USCB $88,094,000.00
- ENGN N/A
- Revenue This Year
- USCB $25.60
- ENGN N/A
- Revenue Next Year
- USCB $5.04
- ENGN N/A
- P/E Ratio
- USCB $11.74
- ENGN N/A
- Revenue Growth
- USCB 32.06
- ENGN N/A
- 52 Week Low
- USCB $13.90
- ENGN $2.65
- 52 Week High
- USCB $21.86
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- USCB 52.89
- ENGN 81.05
- Support Level
- USCB $17.14
- ENGN $5.52
- Resistance Level
- USCB $17.52
- ENGN $6.54
- Average True Range (ATR)
- USCB 0.45
- ENGN 0.55
- MACD
- USCB -0.02
- ENGN 0.14
- Stochastic Oscillator
- USCB 40.12
- ENGN 96.80
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.